TCL Archive Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget December 7, 2012
TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007